» Articles » PMID: 32412051

Long Non-coding RNA SNHG16 Regulates Cell Behaviors Through MiR-542-3p/HNF4α Axis Via RAS/RAF/MEK/ERK Signaling Pathway in Pediatric Neuroblastoma Cells

Overview
Journal Biosci Rep
Specialty Cell Biology
Date 2020 May 16
PMID 32412051
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Neuroblastoma (NB) is an extracranial solid tumor in children with complex mechanism. Increasing reports indicated that long non-coding RNA (lncRNA) small nucleolar RNA host gene 16 (SNHG16) account for the pathogenesis of NB. Nevertheless, the precise functions of SNHG16 needed to be further exposed in NB progression. Our data revealed that SNHG16 and hepatocyte nuclear factor 4 α (HNF4α) were up-regulated, but miR-542-3p was down-regulated in NB. Knockdown of SNHG16 or HNF4α could impede cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) in vitro. Interestingly, the role of SNHG16 detetion in cell behaviors was rescued by HNF4α overexpression in NB cells. Mechanically, SNHG16 modulated the progression of tumor growth via miR-542-3p/HNF4α axis in NB. Also, SNHG16 knockdown inactivated rat sarcoma/effector of RAS/mitogen-activated extracellular signal-regulated kinase/extracellular regulated protein kinases (RAS/RAF/MEK/ERK) signaling pathway through HNF4α. Therefore, SNHG16/miR-542-3p/HNF4α axis modified NB progression via RAS/RAF/MEK/ERK signaling pathway, might highlight a novel therapeutic approach for NB.

Citing Articles

Long Non-Coding RNAs, Nuclear Receptors and Their Cross-Talks in Cancer-Implications and Perspectives.

Tiwari P, Tripathi L Cancers (Basel). 2024; 16(16).

PMID: 39199690 PMC: 11352509. DOI: 10.3390/cancers16162920.


Long Non-Coding RNAs in Neuroblastoma: Pathogenesis, Biomarkers and Therapeutic Targets.

Vercouillie N, Ren Z, Terras E, Lammens T Int J Mol Sci. 2024; 25(11).

PMID: 38891878 PMC: 11171840. DOI: 10.3390/ijms25115690.


Targeted Activation of HNF4α by AMPK Inhibits Apoptosis and Ameliorates Neurological Injury Caused by Cardiac Arrest in Rats.

Zhan H, Zhang Q, Zhang C, Cheng J, Yang Y, Liu C Neurochem Res. 2023; 48(10):3129-3145.

PMID: 37338793 PMC: 10471732. DOI: 10.1007/s11064-023-03957-1.


Role of non-coding RNAs in neuroblastoma.

Anoushirvani A, Jafarian Yazdi A, Amirabadi S, Ahmadi Asouri S, Shafabakhsh R, Sheida A Cancer Gene Ther. 2023; 30(9):1190-1208.

PMID: 37217790 DOI: 10.1038/s41417-023-00623-0.


Roles of lncRNAs in childhood cancer: Current landscape and future perspectives.

Liu F, Xiong Q, Wang J, Peng W Front Oncol. 2023; 13:1060107.

PMID: 36923440 PMC: 10008945. DOI: 10.3389/fonc.2023.1060107.


References
1.
Oshima T, Kawasaki T, Ohashi R, Hasegawa G, Jiang S, Umezu H . Downregulated P1 promoter-driven hepatocyte nuclear factor-4alpha expression in human colorectal carcinoma is a new prognostic factor against liver metastasis. Pathol Int. 2007; 57(2):82-90. DOI: 10.1111/j.1440-1827.2006.02061.x. View

2.
Whittle S, Smith V, Doherty E, Zhao S, McCarty S, Zage P . Overview and recent advances in the treatment of neuroblastoma. Expert Rev Anticancer Ther. 2017; 17(4):369-386. DOI: 10.1080/14737140.2017.1285230. View

3.
He T, Qi F, Jia L, Wang S, Song N, Guo L . MicroRNA-542-3p inhibits tumour angiogenesis by targeting angiopoietin-2. J Pathol. 2014; 232(5):499-508. DOI: 10.1002/path.4324. View

4.
Chen H, Li M, Huang P . LncRNA SNHG16 Promotes Hepatocellular Carcinoma Proliferation, Migration and Invasion by Regulating miR-186 Expression. J Cancer. 2019; 10(15):3571-3581. PMC: 6603422. DOI: 10.7150/jca.28428. View

5.
Klingenberg M, Matsuda A, Diederichs S, Patel T . Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets. J Hepatol. 2017; 67(3):603-618. DOI: 10.1016/j.jhep.2017.04.009. View